3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
8
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Prostatic Neoplasms
4404
Urinary Bladder Neoplasms
1080
Carcinoma, Renal Cell
1042
Kidney Neoplasms
568
Breast Neoplasms
454
Neoplasms
406
Carcinoma, Transitional Cell
301
Neoplasm Metastasis
251
Lung Neoplasms
243
Testicular Neoplasms
202
Melanoma
196
Colorectal Neoplasms
194
Ovarian Neoplasms
165
Carcinoma, Non-Small-Cell Lung
150
Non-Muscle Invasive Bladder Neoplasms
136
Sarcoma
135
Pancreatic Neoplasms
125
Colonic Neoplasms
121
Head and Neck Neoplasms
117
Uterine Cervical Neoplasms
116
Wilms Tumor
108
Recurrence
106
Motor Activity
100
Urologic Neoplasms
90
Stomach Neoplasms
89
Neuroblastoma
88
Disease
85
Multiple Myeloma
83
Carcinoma, Hepatocellular
81
Adenocarcinoma
79
Interventions
radium Ra 223 dichloride
1
niraparib
1
enzalutamide
1
darolutamide
1
capivasertib
1
cabazitaxel
1
apalutamide
1
abiraterone
1
Solutions
1
Prednisone
1
Injections
1
Docetaxel
1
Carboplatin
1
Abiraterone Acetate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Metastatic Castration-resistant Prostate Cancer (mCRPC)
×
Genitourinary
×
Clear all
NCT03903835
2025-04-09
ProBio
Karolinska Institutet
Phase 3
Recruiting
750 enrolled